Hematología y Hemoterapia : [234]

Browse

 
 

Collections in this community

DA - CUN - Hematología y Hemoterapia - Comunicaciones a congresos, Conferencias ... [1]

La divulgación en Dadun puede ser tenida en cuenta y afectar negativamente a la patentabilidad futura de resultados incluidos en la presentación. Si el investigador o su grupo prevén que los resultados expuestos en la presentación, o parte de ellos, pueden ser o serán objeto de una solicitud de patente posterior no deberán incorporar dicha presentación en Dadun. En tal caso se le recomienda consultar con el ICT la manera más adecuada de proceder

Recent Submissions

Matrix metalloproteinase-10 deficiency delays atherosclerosis progression and plaque calcification

Anti-PD1 associated fulminant myocarditis after a single pembrolizumab dose: the role of occult pre-existing autoimmunity

CM-352 Efficacy in a mouse model of anticoagulant-associated intracranial hemorrhage

Central nervous system prophylaxis with intrathecal liposomal cytarabine in a subset of high-risk patients with diffuse large B-cell lymphoma receiving first line systemic therapy in a prospective trial

A Fibrosis Biomarker Early Predicts Cardiotoxicity Due to Anthracycline-Based Breast Cancer Chemotherapy

A phase II multicenter study of the anti-CD19 antibody drug conjugate coltuximab ravtansine (SAR3419) in patients with relapsed or refractory diffuse large B-cell lymphoma previously treated with rituximab-based immunotherapy

Bendamustine as part of conditioning of autologous stem cell transplantation in patients with aggressive lymphoma: a phase 2 study from the GELTAMO group

A new prognostic model identifies patients aged 80 years and older with diffuse large B-cell lymphoma who may benefit from curative treatment: A multicenter, retrospective analysis by the Spanish GELTAMO group

Lenalidomide in combination with R-ESHAP in patients with relapsed or refractory diffuse large B-cell lymphoma: a phase 1b study from GELTAMO group

Immunochemotherapy With Obinutuzumab or Rituximab for Previously Untreated Follicular Lymphoma in the GALLIUM Study: Influence of Chemotherapy on Efficacy and Safety